News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Esperion Therapeutics, Inc. (ESPR) to Present at BioCentury Newsmakers in the Biotech Industry Conference



9/24/2013 6:33:57 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Esperion Therapeutics, Inc. (Nasdaq: ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia, today announced that Tim M. Mayleben, Esperion’s president and chief executive officer, will present at the BioCentury Newsmakers in the Biotech Industry Conference in New York. Mr. Mayleben’s presentation will take place on Friday, September 27 at 2:00 ET at the Millennium Broadway Hotel and Conference Center.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES